Discover
CYTH
Cyclo Therapeutics, Inc.
0.72
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 22.14% | |
| 1y | -49.61% |
0.72
day range
0.72
52 week range
| Open | 0.66 | Prev Close | 0.72 | Low | 0.72 | High | 0.72 | Mkt Cap | N/A |
| Vol | 186.81K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -0.91 |
| Beta | -0.38 | Short Ratio | 3.82 | Inst. Own | 13.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 0.95 |
| Income Statement | |||
| Total Revenue | 233.77K | ||
| Revenues (USD) | 233.77K | ||
| Cost of Revenue | 16.80K | ||
| Gross Profit | 216.97K | ||
| Operating Expenses | 8.51M | ||
| Research and Development Expense | 5.49M | ||
| Selling, General and Administrative Expense | 1.60M | ||
| Operating Income | -8.29M | ||
| Net Income | -8.83M | ||
| Net Income Common Stock | -8.83M | ||
| Net Income Common Stock (USD) | -8.83M | ||
| Consolidated Income | -8.83M | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -8.83M | ||
| Earning Before Interest & Taxes (USD) | -8.83M | ||
| Weighted Average Shares | 28.73M | ||
| Weighted Average Shares Diluted | 28.73M | ||
| Balance Sheet | |||
| Cash and Equivalents | 928.01K | ||
| Cash and Equivalents (USD) | 928.01K | ||
| Trade and Non-Trade Receivables | 187.68K | ||
| Current Assets | 3.26M | ||
| Property, Plant & Equipment Net | 46.62K | ||
| Total Assets | 5.25M | ||
| Debt Current | 12.20M | ||
| Total Debt | 12.21M | ||
| Current Liabilities | 18.72M | ||
| Debt Non-Current | 7.14K | ||
| Total Liabilities | 18.73M | ||
| Accumulated Retained Earnings (Deficit) | -103.01M | ||
| Shareholders Equity | -13.47M | ||
| Shareholders Equity (USD) | -13.47M | ||
| Assets Non-Current | 2.00M | ||
| Total Debt (USD) | 12.21M | ||
| Inventory | 236.11K | ||
| Liabilities Non-Current | 7.14K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.18K | ||
| Net Cash Flow from Financing | 8.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -193.80K | ||
| Issuance (Repayment) of Debt Securities | 8.00M | ||
| Net Cash Flow from Operations | -8.19M | ||
| Share Based Compensation | 269.58K | ||